Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
05/10/2007 | WO2007053498A1 Compounds useful as antagonists of ccr2 |
05/10/2007 | WO2007053495A2 Compounds useful as antagonists of ccr2 |
05/10/2007 | WO2007053394A1 Kinase inhibitors |
05/10/2007 | WO2007053131A2 Acrylamide derivatives as antibiotic agents |
05/10/2007 | WO2007053082A1 Novel 1 -benzyl-4-piperidinamines that are useful in the treatment of copd and asthma |
05/10/2007 | WO2007052943A1 Novel antifungal triazole derivatives |
05/10/2007 | WO2007052843A1 Heterocyclic amide compound and use thereof |
05/10/2007 | WO2007052615A1 Pyridine derivative substituted by heterocycle and fungicide containing the same |
05/10/2007 | WO2007051982A1 Triazole compounds as lipoxygenase inhibitors |
05/10/2007 | WO2007051981A1 Pyrazoles useful in the treatment of inflammation |
05/10/2007 | WO2007051619A1 N- (hetero) aryl indole derivatives as pesticides |
05/10/2007 | WO2007025709A3 Organic compounds |
05/10/2007 | WO2007015017A3 Novel polyquinoline derivatives and the therapeutic use thereof |
05/10/2007 | WO2006131835A3 Heterocyclic triazines as hypoxic selective protein kinase inhibitors |
05/10/2007 | WO2006127205A3 Methods of preparing 3-cyano-quinolines and intermediates made thereby |
05/10/2007 | WO2006120573A3 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors |
05/10/2007 | WO2006105081A3 Pharmacokinetically improved compounds |
05/10/2007 | WO2006063113A3 Ureas as factor xa inhibitors |
05/10/2007 | WO2006002873A3 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri ) |
05/10/2007 | WO2002010431A3 Functional biopolymer modification reagents and uses thereof |
05/10/2007 | US20070105932 2H-or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof |
05/10/2007 | US20070105926 Tetrazoyloxime derivative and agricultural chemical containing the same as active ingredient |
05/10/2007 | US20070105903 Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs |
05/10/2007 | US20070105901 Novel piperidine derivative |
05/10/2007 | US20070105899 Benzene compounds |
05/10/2007 | US20070105893 e.g. 2-[(4-Ethoxyphenyl)methyl]-1-(3-methylbutyl)-N,N-bis(2,2,2-trifluoroethyl)-1H-benzimidazole-5-carboxamide; agonists at cannabinoid 2 receptor; analgesic agent, anticarcinogenic agent, neurodegenerative diseases; multiple sclerosis, Parkinson's disease, Huntington's chorea or Alzheimer's disease. |
05/10/2007 | US20070105881 For improving perception, concentration, learning or memory; 2-(Cyclopentylmethyl)-4-[(fluorophenyl)amino]6-oxo-1,6-dihydro-5-pyrimidinecarbonitrile; amination of methyl 2-cyano propenoate derivatives, cyclization using amidinehydrochloride derivatives |
05/10/2007 | US20070105865 Substituted bicyclic quinazolin-4-ylamine derivatives |
05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
05/10/2007 | US20070105858 Retinoic acid mimetic anilides |
05/10/2007 | US20070105855 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
05/10/2007 | US20070105854 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
05/10/2007 | US20070105853 2-'4-(Hydroxymethyl-phenylamino)-piperidine-1-yl!-n-(9h-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
05/10/2007 | US20070105846 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
05/10/2007 | US20070105839 2, 4-Di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
05/10/2007 | US20070105838 Bicyclic Benzamide Compoundssa as Histamine H3 Receptor Ligand Useful in the Treatment of Neurological Diseases |
05/10/2007 | US20070105834 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide |
05/10/2007 | US20070103060 Platinum complex and light emitting device |
05/10/2007 | CA2628259A1 Dihydroisoindolones as allosteric modulators of glucokinase |
05/10/2007 | CA2627910A1 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
05/10/2007 | CA2627892A1 Substituted dihydroisoindolones as allosteric modulators of glucokinase |
05/10/2007 | CA2627813A1 Substituted pyrrolones as allosteric modulators of glucokinase |
05/10/2007 | CA2627673A1 Kinase inhibitors |
05/10/2007 | CA2627516A1 Triazole compounds as lipoxygenase inhibitors |
05/10/2007 | CA2626300A1 N-(hetero) aryl indole derivatives as pesticides |
05/09/2007 | EP1783126A2 N-oxides of N-phenyl-2-pyrimidine-amine derivatives |
05/09/2007 | EP1783125A1 Method for producing 2-(4-methyl-2-phenylpiperazine-1-yl)-3-cyanopiridine |
05/09/2007 | EP1783116A1 2-phenylpyridine derivative |
05/09/2007 | EP1783114A1 N-(hetero)aryl indole derivatives as pesticides |
05/09/2007 | EP1781650A1 Novel compounds having an anti-bacterial activity |
05/09/2007 | EP1781640A1 2,4-di(aminophenyl)pyrimidine derivatives as plk inhibitors |
05/09/2007 | EP1781639A1 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
05/09/2007 | EP1781638A2 Imidazolo-related compounds, compositions and methods for their use |
05/09/2007 | EP1781637A1 2-substituted quinoline compounds and their uses as inhibitors of the ige receptor signaling cascade |
05/09/2007 | EP1781636A1 Pyrrole derivatives, their preparation and their therapeutic use |
05/09/2007 | EP1781635A2 Potassium channel inhibitors |
05/09/2007 | EP1781623A1 Compounds and compositions useful as cathepsin s inhibitors |
05/09/2007 | EP1781621A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
05/09/2007 | EP1781620A1 Novel beta agonists, method for producing the same and their use as drugs |
05/09/2007 | EP1781619A1 Sigma receptor inhibitors |
05/09/2007 | EP1781618A1 Sigma receptor inhibitors |
05/09/2007 | EP1781617A2 Alpha, beta-unsaturated esters and acids by stereoselective dehydration |
05/09/2007 | EP1781613A1 Piperidine derivatives as histamine h3 receptor ligands |
05/09/2007 | EP1781606A2 Azetidine derivatives as ccr-3 receptor antagonists |
05/09/2007 | EP1781293A1 Quinoline- and isoquinoline-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
05/09/2007 | EP1680418B1 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
05/09/2007 | EP1654229B1 Piperidine derivatives as ccr5 receptor modulators |
05/09/2007 | EP1572667B1 Cathepsin cysteine protease inhibitors and their use in the treatment of inflammation and immune disorders |
05/09/2007 | EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
05/09/2007 | EP1408970B1 Indolines and tetrahydro-quinolines as prodrugs for tumour treatment |
05/09/2007 | EP1272477B1 Pyrimidine compounds |
05/09/2007 | EP1238970B9 Cycloamine ccr5 receptor antagonists |
05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
05/09/2007 | EP1183245B1 Selective npy (y5) antagonists |
05/09/2007 | CN1960990A Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
05/09/2007 | CN1960988A Compounds and compositions as protein kinase inhibitors |
05/09/2007 | CN1960987A Process for the preparation of pyridin-2-ylmethylsulphinyl-1H-benzimidazol compounds |
05/09/2007 | CN1960986A Butyrylcholinesterase selective inhibitors |
05/09/2007 | CN1960985A Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
05/09/2007 | CN1960984A Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as MGLU5 receptor antagonists |
05/09/2007 | CN1960979A Triazolone derivatives as MMP inhibitors for the treatment of asthma and copd |
05/09/2007 | CN1960977A Quinazoline derivative |
05/09/2007 | CN1960975A Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP) |
05/09/2007 | CN1960971A Substituted pyrrolidine-2-ones |
05/09/2007 | CN1960970A Pyrrolidine derivatives as CB1-receptor antagonists |
05/09/2007 | CN1960969A Histamine H3 receptor agents, preparation method and therapeutic uses thereof |
05/09/2007 | CN1960727A Naphthalene derivatives useful as histamine-3-receptor ligands |
05/09/2007 | CN1958572A Compound in category of dihydro quinolines, preparation method, and composition of medication |
05/09/2007 | CN1314739C Composition stabilized against thermal, oxidative or light-induced degradation and its preparing process |
05/09/2007 | CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
05/09/2007 | CN1314682C Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
05/09/2007 | CN1314681C 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity |
05/09/2007 | CN1314669C 2,7-substituted indoles and their use as 5-HT6 modulators |
05/09/2007 | CN1314393C Method for treating hair-dropping using thyromimetic compound |
05/08/2007 | US7214802 Anti-cytokine heterocyclic compounds |
05/08/2007 | US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
05/08/2007 | US7214799 Protecting the hydroxyls of 3-hydroxy-4,5-dimethylol-2-picoline, reacting the 4-methylol group with an imide (especially potasssium phthalimide), cleaving the imide group to deprotect the amine group, and deprotecting the remaining hydroxy groups |
05/08/2007 | US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics |
05/08/2007 | US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases |
05/08/2007 | US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |